Hong Kong Household Products Stock News

If you're looking for a multi-bagger, there's a few things to keep an eye out for. In a perfect world, we'd like to see...

Lotus Horizon Holdings Limited's ( HKG:6063 ) price-to-sales (or "P/S") ratio of 1.4x may not look like an appealing...

Global International Credit Group Limited ( HKG:1669 ) stock is about to trade ex-dividend in 4 days. The ex-dividend...

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...

To the annoyance of some shareholders, Majestic Dragon AeroTech Holdings Limited ( HKG:918 ) shares are down a...

China Unicom (Hong Kong) Limited's ( HKG:762 ) robust earnings report didn't manage to move the market for its stock...

Beijing Beida Jade Bird Universal Sci-Tech ( HKG:8095 ) First Half 2025 Results Key Financial Results Revenue...

ZhongAn Online P & C Insurance Co., Ltd.'s ( HKG:6060 ) price-to-earnings (or "P/E") ratio of 23.3x might make it look...

As global markets navigate a period of economic uncertainty, with mixed signals from major economies such as the U.S. and China, investors are increasingly looking toward Asia for opportunities in growth stocks. In this context, companies with high insider ownership can offer an added layer of confidence, as significant insider stakes often align management's interests with those of shareholders and may indicate potential resilience amid fluctuating market conditions.

AsiaInfo Technologies' (HKG:1675) stock is up by a considerable 21% over the past three months. However, we wonder if...

Amidst a backdrop of global economic shifts, Asian markets have been navigating through a mix of optimism and caution, with China's stock markets recently experiencing volatility due to domestic liquidity surges and broader economic concerns. In this dynamic environment, identifying high-growth tech stocks requires a keen eye on innovation potential and resilience in the face of fluctuating market conditions.

Sunny Optical Technology (Group) ( HKG:2382 ) First Half 2025 Results Key Financial Results Revenue: CN¥19.7b (up 4.2...

E&P Global Holdings Limited ( HKG:1142 ) shareholders have seen the share price descend 30% over the month. But that...

Despite an already strong run, Zhong An Intelligent Living Service Limited ( HKG:2271 ) shares have been powering on...

Viewing insider transactions for HKT Trust and HKT Limited's ( HKG:6823 ) over the last year, we see that insiders were...

As the Asian markets navigate a complex global landscape marked by economic uncertainties and shifting interest rate expectations, investors are increasingly seeking opportunities that offer both stability and growth potential. Penny stocks, despite their somewhat outdated moniker, remain an intriguing investment area for those looking to explore smaller or newer companies with promising financial health. In this article, we spotlight several penny stocks in Asia that stand out for their...

XtalPi Holdings (SEHK:2228) recently announced a significant milestone as its next-generation PRMT5 inhibitor, PEP08, received regulatory approvals to begin Phase 1 clinical trials for solid tumors. This development underscores the company's advanced capabilities in drug discovery, likely contributing to the impressive 65% rise in its stock price over the last quarter. Alongside broader tech market gains, highlighted by the S&P 500 and Nasdaq reaching new highs, XtalPi's earnings reports...

Cirrus Aircraft (SEHK:2507) reported a strong earnings performance for the half year ended June 30, 2025, with sales rising to USD 594 million from USD 475 million, and net income increasing to USD 65 million, providing a potential catalyst for its share price increase of 42% over the last quarter. These financial results likely underscored confidence in the company amidst a generally robust market environment, where the S&P 500 and Nasdaq hit all-time highs. The company's dividend...

Jiangxi Rimag Group (SEHK:2522) experienced a notable 14% price move over the last quarter. This upward trend coincided with positive developments such as the announcement of robust half-year earnings, showcasing a significant increase in sales and net income. Additionally, the completion of a substantial follow-on equity offering may have further boosted investor confidence. During this period, broader market indices like the S&P 500 and Nasdaq also reached all-time highs. While the...

NetEase Cloud Music (SEHK:9899) reported a noteworthy financial turnaround with its recent earnings release, showcasing a significant rise in net income and earnings per share, despite a decline in sales from the previous year. These developments may have added weight to the company's 18% price increase last quarter amid a robust market environment with the S&P 500 and Nasdaq hitting all-time highs. The half-year results reflect operational efficiencies and effective cost management...

Pop Mart International Group (SEHK:9992) saw its shares rise by 3.15% over the last quarter, a period marked by key developments like its inclusion in both the Hang Seng Index and the Hang Seng China Enterprises Index on September 8, 2025. This addition underscores the company's growing prominence following impressive financial results reported on August 19, 2025, which showed significant year-over-year gains in sales and net income. During this time, major indices like the S&P 500 and Nasdaq...

Akeso (SEHK:9926) recently captured attention by presenting promising data on its cadonilimab therapy at the World Conference on Lung Cancer, highlighting its potential as a breakthrough treatment for immunotherapy-resistant non-small cell lung cancer. Over the last quarter, the company's share price surged 40%, potentially influenced by these significant clinical developments and the awarding of Breakthrough Therapy Designation. The broader market trend, which saw indices like the S&P 500...

Alphamab Oncology (SEHK:9966) recently reported favorable earnings for the half year ended June 2025, showcasing a revenue increase to CNY 319 million and a net income turnaround to CNY 21 million from a prior loss. This aligns well with their earlier guidance that anticipated a profit shift, bolstered by milestones from licensed collaborations. Amid these events, the company's stock rose 31% in the last quarter. The positive trajectory might have been bolstered by the overall robust market...

Ascletis Pharma (SEHK:1672) recently announced noteworthy advancements related to its investigational drug ASC30, showcasing a promising 75-day half-life in a clinical study, which propelled excitement around potential once-quarterly administration for obesity management. As a result, the company's share price increased by nearly 48% over the last quarter. This rise occurred against a backdrop of broader market gains, with indexes like the Nasdaq and S&P 500 reaching all-time highs,...